Adverse events after administration of tetanus-diphtheria-acellular pertussis vaccine to healthcare workers

Infection Control and Hospital Epidemiology

Volumn 30, Issue 4, 2009, Pages 389-391

  Sandora, Thomas J ^a,b,d   Pfoh, Elizabeth ^c   Lee, Grace M ^a,b,c  

^a Division of Infectious Diseases   (United States)

^b Department of Laboratory Medicine ^*  (United States)

^c HARVARD PILGRIM HEALTH CARE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ABNORMAL SENSATION; ADULT; AGE; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COUNSELING; DIZZINESS; DRUG EXPOSURE; DRUG FEVER; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FLU LIKE SYNDROME; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INJECTION SITE CONTUSION; INJECTION SITE DISCOLORATION; INJECTION SITE EDEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; LIMB SWELLING; LYMPHADENOPATHY; MALE; MUSCLE WEAKNESS; MYALGIA; NAUSEA AND VOMITING; NORMAL HUMAN; OUTCOME ASSESSMENT; PARESTHESIA; PRURITUS; RADIAL NERVE PALSY; RISK ASSESSMENT; SEX DIFFERENCE; SKIN BRUISING; VACCINATION;

ADULT; DIPHTHERIA; DIPHTHERIA-TETANUS VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HOSPITALS, PEDIATRIC; HUMANS; IMMUNIZATION, SECONDARY; INTERNET; MALE; MIDDLE AGED; PAIN; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; TETANUS; TIME FACTORS; WHOOPING COUGH;

EID: 63549136652     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/596201     Document Type: Article

References (10)

1. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among healthcare personnel. MMWR Recomm Rep 2006; 55(RR-17):1-37.
2. Halperin SA, Sweet L, Baxendale D, et al. How soon after a prior tetanusdiphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J 2006; 25:195-200.
3. Rennels MB. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis 2003; 14:196-198.
4. Sekaran NK, Edwards KM. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine. Pediatr Infect Dis J 2006; 25:374-375.
5. Halperin SA, Smith B, Russell M, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is sate and immunogenic in adolescents and adults. Vereine 2000; 18:1312-1319.
6. Pichichero ME, Rennels MB, Edwards KM, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005; 293:3003-3011.
7. Turnbull FM, Heath TC, Jalaludin BB, Burgess MA, Ramalho AC. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine 2000; 19: 628-636.
8. Van der Wielen M, Van Damme P, Joossens E, Francois G, Meurice F, Ramalho A. A randomised controlled trial with a diphtheria-tetanusacellular pertussis (dTpa) vaccine in adults. Vaccine 2000; 18:2075-2082.
9. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555-1563.
10. Woo EJ, Burwen DR, Gatumu SN, Ball R. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis 2003; 37:351-358.